Melatonin Neurim Den Europæiske Union - polsk - EMA (European Medicines Agency)

melatonin neurim

rad neurim pharmaceuticals eec sarl - melatonina - zaburzenia inicjacji snu i utrzymania - psycholeptyki - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Quviviq Den Europæiske Union - polsk - EMA (European Medicines Agency)

quviviq

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - zaburzenia inicjacji snu i utrzymania - psycholeptyki - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.